Methods for performing a coronary artery bypass graft procedure
US2016151444A1
Methods for the prevention or treatment of vessel occlusion injury
CA2895743A1
Therapeutic compositions including gramicidin s peptidyl conjugates or imidazole-substituted fatty acids, variants thereof and uses thereof to treat and prevent mitochondrial diseases and conditions
WO2015195737A1
Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening
CA2894005A1
Therapeutic compositions including skq compounds and uses thereof to treat and prevent mitochondrial diseases and conditions
WO2016200364A1
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
CA2893245A1
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof to treat and prevent mitochondrial diseases and disorders
WO2016195663A1
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
WO2015183984A2
Therapeutic compositions including tocopherol and uses thereof
WO2015183985A2
Therapeutic compositions including naphthoquinones and uses thereof
WO2015183963A2
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
WO2015183970A1
Therapeutic compositions including flavonoid and uses thereof
WO2015183995A2
Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
WO2016190852A1
Therapeutic compositions including chromanyl compounds, variants and analogues thereof, and uses thereof
CA2893402A1
Therapeutic compositions including chromanyl compounds, variants and analogues thereof, and uses thereof to treat and prevent mitochondrial diseases and conditions
WO2016144352A2
Therapeutic compositions including acrylamido compounds or phenyl-substituted maleimide compounds, variants thereof and methods of using the same
CA2884607A1
Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions
CA2881746A1
Therapeutic compositions including mitochondrial fission inhibitor peptides, variants thereof, and methods of using the same to treat and prevent mitochondrial diseases and conditions
WO2016130143A2
Therapeutic compositions including mitochondrial fission inhibitor peptides, variants thereof and methods of using the same
WO2015103577A1
Methods and compositions for preventing or treating dominant optic atrophy
